首页> 中文期刊> 《中国医院用药评价与分析》 >2012-2014年上海长征医院抗肿瘤中药注射剂使用情况分析

2012-2014年上海长征医院抗肿瘤中药注射剂使用情况分析

         

摘要

目的:了解上海长征医院(以下简称“我院”)抗肿瘤中药注射剂的临床使用情况,为安全、有效、经济地使用抗肿瘤中药注射剂提供参考。方法:检索住院药房医院信息管理系统数据库,采用金额排序法和限定日剂量分析法对我院2012—2014年抗肿瘤中药注射剂的应用情况进行统计分析。结果:2012—2014年,我院抗肿瘤中药注射剂的销售金额和用药频度( DDDs)逐年增加,销售金额占各年中药注射剂总销售金额的比例分别为75.3%、72.9%、73.4%;3年来,康艾注射液的销售金额和DDDs均稳居首位。结论:近年来,抗肿瘤中药注射剂的使用量增长迅速,须加强用药管理和不良反应监测。%OBJECTIVE:To investigate the utilization of antitumor traditional Chinese medicine injections (ATCMI) in Shanghai Changzheng Hospital(hereinafter referred to as “our hospital”) during 2012-2014 period for references of clinical safe, effective and economical use of drugs.METHODS: The utilization data of ATCMI in our hospital during 2012-2014 were retrieved from hospital information management system for statistical analysis by ranking consumption sum and defined daily dose ( DDD) .RESULTS:The consumption sum of ATCMI in our hospital during 2012-2014 increased year by year, accounting for 75.3%, 72.9% and 73.4%, respectively of the total consumption sum of TCM injections.Kangai injection took the lead in terms of both consumption sum and DDDs over the 3 years.CONCLUSIONS:The consumption of antitumor traditional Chinese medicine injections witnessed a rapid increase in recent years.It is urgent to tighten management on drug use and monitoring on adverse drug reactions.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号